Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Cash & Equivalents · Q4 FY2024 · quarter ended Mar 2025
Cash & equivalents falls 61.2% from a year ago
Cash & equivalents stood at $816.77K at the end of Q4 FY2024, down 61.2% from a year earlier.
Context
- Cash & equivalents amounted to 15.3% of total assets at the end of Q4 FY2024, down 27.8 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -61.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2024
- 816.77K USD
- Year-over-year change
- -61.2%
- 2-year CAGR
- -34.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 816.77K | -61.2% |
| FY2023 | 2024-03-31 | 2.1M | +9.0% |
| FY2022 | 2023-03-31 | 1.93M | — |
Cash & Equivalents vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 cash & equivalents of $816.77K is the lowest of the 10 companies compared; the peer median is $41.31M.
- Its year-over-year change of -61.2% is the lowest of 10, against a peer median of +30.8%.
- Cash & equivalents amounts to 15.3% of total assets for MCTA, versus a peer median of 18.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $175.21M | +80.4% | +5.0% | 66.6% | |
| Mar 2026 | $139.99M | +1.0% | -28.0% | 9.3% | |
| Mar 2026 | $105.58M | +30.8% | +211.3% | 23.4% | |
| Mar 2026 | $74.99M | -10.3% | +56.1% | 27.6% | |
| Mar 2026 | $41.31M | +223.4% | +78.3% | 33.1% | |
| Mar 2026 | $35.3M | +2994.9% | +394.4% | 5.7% | |
| Mar 2026 | $30.28M | -23.8% | +33.8% | 18.0% | |
| Feb 2026 | $25.73M | +134.1% | -15.7% | 17.6% | |
| Mar 2026 | $17.57M | -37.2% | +19.0% | 5.8% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $816.77K | -61.2% | — | 15.3% |
| Peer median (excluding MCTA) | $41.31M | +30.8% | +33.8% | 18.0% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.